Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106)

Summary

Long-Term Follow-up Study of Subjects With Moderate to Severe Chronic Atopic Dermatitis Who Had Administered FURESTEM-AD Inj. in K0106 Study

Conditions

• Dermatitis, Atopic

Sponsors & Collaborators

• Kang Stem Biotech Co., Ltd.

  lead INDUSTRY

Principal Investigators

• Yeonglib Park, professor (CI) · Bucheon Hospital, Soonchunhyang University

• Yangwon Lee, professor · Konkuk University Hospital

• Sanguk Son, professor · Korea University Ansan Hospital

• Bakrin Yoo, professor · Gangdong Kyunghee University Hospital

• Jihyun Lee, professor · Seoul St. Mary's Hospital

• Donghoon Lee, professor · Seoul National University Hospital

• Chanho Na, professor · Chosun University Hospital

• Yooin Bae, professor · Hallym University Dongtan Seongsim Hospital

• Hyunchang Ko, professor · Yangsan Pusan National University Hospital

• Younghyun Jang, professor · Kyungpook National University Hospital

• Hoon Kang, professor · The Catholic University of Korea Eunpyeong St. Mary's Hospital

• Minkyung Shin, professor · Kyunghee University Hospital

• Sanghyun Cho, professor · Catholic University Incheon St. Mary's Hospital

• Cheonuk Park, professor · Hallym University Kangnam Sacred Heart Hospital

• Jooyeon Ko, professor · Hanyang University

• Taeyoung Han, professor · Nowon Eulji University Hospital

• Jiyoung Ahn, professor · National medical center

• Yuchan Kim, professor · Ajou University School of Medicine

• Sungyeol Lee, professor · Soon Chun Hyang University

• Junhong Min, professor · KangWon National University Hospital

Eligibility

Min Age

19 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-10-05

Primary Completion

2028-08-21

Completion

2029-02-21

Countries

• South Korea

Study Locations